Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire Chubb Life Hong Kong Launches Serene Care Critical Illness Protector - The Market's Only Pure Critical Illness Basic Plan with Limited Premium Payment Terms